Skip to content

Cyclophosphamide

Cyclophosphamide (Cytoxan) is a chemotherapy medicine used to treat lymphoma, multiple myeloma, and nephrotic syndrome. This listing covers the one tablet formulation in the catalogue.

Cytoxan

Malignant Lymphomas, Multiple Myeloma

50mg

Cyclophosphamide tablets for malignant lymphomas and multiple myeloma. It damages the DNA of cancer cells to stop them from multiplying.

From$1.76/ tabletView

Key points

  • Cytoxan is the sole brand listed in this catalogue, with one generic formulation of cyclophosphamide.
  • Cyclophosphamide is an alkylating agent, a class of chemotherapy medicine that slows or stops the growth of cancer cells.
  • The tablet carries a fixed strength of 50mg.

Common questions about Cyclophosphamide

What category does Cyclophosphamide belong to?

Cyclophosphamide is listed under the Oncology Support category. It is a chemotherapy ingredient used for Malignant Lymphomas, Multiple Myeloma, and nephrotic syndrome. The active ingredient is cyclophosphamide, supplied as a 50mg tablet.

What is the originator brand behind Cyclophosphamide?

Bristol-Myers Squibb is the originator behind Cyclophosphamide, marketed as Cytoxan. The generic formulation contains the same active substance at the same 50mg strength, and every listed product delivers the same medicine regardless of the name on the pack.

Further reading